A detailed history of Bvf Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Bvf Inc holds 4,786,293 shares of KURA stock, worth $98.5 Million. This represents 3.06% of its overall portfolio holdings.

Number of Shares
4,786,293
Previous 7,373,228 35.09%
Holding current value
$98.5 Million
Previous $106 Million 3.71%
% of portfolio
3.06%
Previous 2.78%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.42 - $23.53 $34.7 Million - $60.9 Million
-2,586,935 Reduced 35.09%
4,786,293 $102 Million
Q4 2023

Feb 14, 2024

BUY
$7.58 - $14.38 $4.87 Million - $9.24 Million
642,245 Added 9.54%
7,373,228 $106 Million
Q1 2023

May 15, 2023

BUY
$10.71 - $14.6 $31.4 Million - $42.8 Million
2,930,000 Added 77.09%
6,730,983 $82.3 Million
Q4 2022

Feb 14, 2023

BUY
$11.23 - $16.9 $6.71 Million - $10.1 Million
597,200 Added 18.64%
3,800,983 $47.2 Million
Q1 2022

May 16, 2022

BUY
$11.78 - $16.98 $13.4 Million - $19.3 Million
1,139,571 Added 55.21%
3,203,783 $51.5 Million
Q4 2021

Feb 14, 2022

BUY
$12.22 - $19.57 $5.24 Million - $8.4 Million
429,100 Added 26.24%
2,064,212 $28.9 Million
Q1 2021

May 17, 2021

BUY
$24.75 - $39.14 $9.63 Million - $15.2 Million
389,200 Added 31.24%
1,635,112 $46.2 Million
Q4 2020

Feb 12, 2021

SELL
$29.0 - $41.62 $7.05 Million - $10.1 Million
-243,200 Reduced 16.33%
1,245,912 $40.7 Million
Q3 2020

Nov 13, 2020

SELL
$16.3 - $30.64 $21 Million - $39.4 Million
-1,286,770 Reduced 46.36%
1,489,112 $45.6 Million
Q2 2020

Aug 14, 2020

BUY
$7.95 - $18.81 $2.71 Million - $6.42 Million
341,186 Added 14.01%
2,775,882 $45.2 Million
Q1 2020

May 15, 2020

BUY
$6.45 - $14.04 $2.81 Million - $6.13 Million
436,420 Added 21.84%
2,434,696 $24.2 Million
Q3 2019

Nov 14, 2019

SELL
$14.75 - $20.87 $3.04 Million - $4.3 Million
-205,843 Reduced 9.34%
1,998,276 $30.3 Million
Q2 2019

Aug 14, 2019

SELL
$14.71 - $19.79 $4.28 Million - $5.76 Million
-291,037 Reduced 11.66%
2,204,119 $43.4 Million
Q1 2019

May 15, 2019

SELL
$13.73 - $16.87 $3.84 Million - $4.72 Million
-280,000 Reduced 10.09%
2,495,156 $41.4 Million
Q4 2018

Feb 14, 2019

BUY
$10.6 - $17.49 $8.05 Million - $13.3 Million
759,300 Added 37.67%
2,775,156 $39 Million
Q3 2018

Nov 14, 2018

SELL
$16.65 - $21.85 $690,808 - $906,556
-41,490 Reduced 2.02%
2,015,856 $35.3 Million
Q2 2018

Aug 14, 2018

BUY
$14.8 - $18.8 $10.4 Million - $13.2 Million
703,500 Added 51.96%
2,057,346 $37.4 Million
Q3 2017

Nov 14, 2017

BUY
$6.05 - $14.95 $8.19 Million - $20.2 Million
1,353,846
1,353,846 $20.2 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $1.38B
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.